本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kura Oncology, Inc

10.85
-0.3550-3.17%
盘后10.75-0.1000-0.92%19:14 EST
成交量:272.41万
成交额:3,018.75万
市值:9.44亿
市盈率:-4.37
高:11.50
开:11.16
低:10.77
收:11.21
52周最高:16.68
52周最低:5.41
股本:8,701.75万
流通股本:6,398.56万
量比:0.97
换手率:4.26%
股息:- -
股息率:- -
每股收益(TTM):-2.4801
每股收益(LYR):-2.0193
净资产收益率:-65.10%
总资产收益率:-26.57%
市净率:3.89
市盈率(LYR):-5.37

数据加载中...

2023/06/12

重要事件披露

Form 8-K - Current report
2023/06/02

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/06/02

重要事件披露

Form 8-K - Current report
2023/05/10

重要事件披露

Form 8-K - Current report
2023/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/19

重要事件披露

8-K - Current report
2023/03/10

重要事件披露

8-K - Current report
2023/02/24

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/23

重要事件披露

8-K - Current report
2023/02/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/13

重要事件披露

8-K - Current report
2023/01/09

重要事件披露

8-K - Current report
2022/12/12

重要事件披露

8-K - Current report